Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla M Nester

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Kidney Medicine|April 11, 2025
Clinical Decision-Making About Immunosuppressive Treatment in Focal Segmental GlomerulosclerosisBrooke Blazius, Jonathan P Troost, Jeffrey B Kopp, et al.
Kidney International|September 24, 2021
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular DiseasesBrad H Rovin, Sharon G Adler, Jonathan Barratt, et al.
Kidney International|November 1, 2013
C3 glomerulopathy: consensus reportMatthew C Pickering, Vivette D D'Agati, Carla M Nester, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
Kidney International Reports|November 20, 2018
Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN StudyDavid T Selewski, Josephine M Ambruzs, Gerald B Appel, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Kidney Medicine|April 11, 2025
Clinical Decision-Making About Immunosuppressive Treatment in Focal Segmental GlomerulosclerosisBrooke Blazius, Jonathan P Troost, Jeffrey B Kopp, et al.
Kidney International|September 24, 2021
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular DiseasesBrad H Rovin, Sharon G Adler, Jonathan Barratt, et al.
Kidney International|November 1, 2013
C3 glomerulopathy: consensus reportMatthew C Pickering, Vivette D D'Agati, Carla M Nester, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
Kidney International Reports|November 20, 2018
Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN StudyDavid T Selewski, Josephine M Ambruzs, Gerald B Appel, et al.
Pageof 7